ABSTRACT
The COVID-19 pandemic has overwhelmed the existing healthcare infrastructure in many parts of the world. Healthcare professionals are not only over-burdened but also at a high risk of nosocomial transmission from COVID-19 patients. Screening and monitoring the health of a large number of susceptible or infected individuals is a challenging task. Although professional medical attention and hospitalization are necessary for high-risk COVID-19 patients, home isolation is an effective strategy for low and medium risk patients as well as for those who are at risk of infection and have been quarantined. However, this necessitates effective techniques for remotely monitoring the patients' symptoms. Recent advances in Machine Learning (ML) and Deep Learning (DL) have strengthened the power of imaging techniques and can be used to remotely perform several tasks that previously required the physical presence of a medical professional. In this work, we study the prospects of vital signs monitoring for COVID-19 infected as well as quarantined individuals by using DL and image/signal-processing techniques, many of which can be deployed using simple cameras and sensors available on a smartphone or a personal computer, without the need of specialized equipment. We demonstrate the potential of ML-enabled workflows for several vital signs such as heart and respiratory rates, cough, blood pressure, and oxygen saturation. We also discuss the challenges involved in implementing ML-enabled techniques. [ABSTRACT FROM AUTHOR] Copyright of Computing is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
ABSTRACT
At a time when the COVID-19's second wave is still picking up in countries like India, a number of reports describe the potential association with a rise in the number of cases of mucormycosis, commonly known as the black fungus. This fungal infection has been around for centuries and affects those people whose immunity has been compromised due to severe health conditions. In this article, we provide a detailed overview of mucormycosis and discuss how COVID-19 could have caused a sudden spike in an otherwise rare disease in countries like India. The article discusses the various symptoms of the disease, class of people most vulnerable to this infection, preventive measures to avoid the disease, and various treatments that exist in clinical practice and research to manage the disease.